Nasal Polyps
📧 Sign up to get email alerts when something new happens for Nasal Polyps.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-13EMA Authorised: Exdensur (depemokimab) — GlaxoSmithKline Trading Services Limited
EMA authorised Exdensur (depemokimab) for asthma and nasal polyps under GlaxoSmithKline Trading Services Limited.
-
EMA approval · 2026-03-12EMA Authorised: Exdensur (depemokimab) — GlaxoSmithKline Trading Services Limited
The EMA authorised Exdensur (depemokimab) for treatment indications in asthma and nasal polyps. Decision date 12 February 2026.
-
FDA approval · 2023-03-09FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mometasone Furoate Nasal (mometasone furoate) submitted by Rugby Laboratories.